VentureMed Group, a leading medical device company specializing in vessel preparation and access management technologies for the treatment of peripheral arterial disease and arteriovenous fistulas and grafts, announced the closing of a $28 million Series C financing round led by S3 Ventures, and joined by existing investors including Endeavour Vision.